CAJ | 학술논문

目的：探讨胸腹腔镜联合下食管癌微创手术临床疗效。方法回顾性分析100例接受胸腹腔镜联合下食管癌微创手术患者（观察组）和100例接受开放性手术食管癌患者（对照组）的临床资料。比较两组患者的手术指标、围手术期并发症和近期疗效。结果观察组患者无死亡，对照组患者死亡2例。观察组手术时间（274.7±67.3） min与对照组的（255.4±49.1） min相比无统计学差异（P＞0.05），观察组患者术中出血量、患者住院时间、胸管留置时间显著低于对照组。观察组患者清扫淋巴结数与术后并发症发生率与对照组相比无统计学差异（P＞0.05）。观察组患者复发率6.3％（6／96）显著低于对照组的17.0％（16／94），P＜0.05。观察组患者生存率94.8％（91／96）显著高于对照组的84.0％（79／94）。结论胸腹腔镜联合下食管癌微创手术临床疗效显著可减少患者术中损伤并预防复发。
목적：탐토흉복강경연합하식관암미창수술림상료효。방법회고성분석100례접수흉복강경연합하식관암미창수술환자（관찰조）화100례접수개방성수술식관암환자（대조조）적림상자료。비교량조환자적수술지표、위수술기병발증화근기료효。결과관찰조환자무사망，대조조환자사망2례。관찰조수술시간（274.7±67.3） min여대조조적（255.4±49.1） min상비무통계학차이（P＞0.05），관찰조환자술중출혈량、환자주원시간、흉관류치시간현저저우대조조。관찰조환자청소림파결수여술후병발증발생솔여대조조상비무통계학차이（P＞0.05）。관찰조환자복발솔6.3％（6／96）현저저우대조조적17.0％（16／94），P＜0.05。관찰조환자생존솔94.8％（91／96）현저고우대조조적84.0％（79／94）。결론흉복강경연합하식관암미창수술림상료효현저가감소환자술중손상병예방복발。
Objective To study in clinical efficacy of thoracoscope and abdominoscope combined with minimally invasive esophageal surgery.Methods The clinical data of 100 patients who received thoracoscope and abdominoscope combined with minimally invasive e -sophageal surgery and 100 patients who received open operation were retrospectively analyzed .The operation indexes ,peri-operative com-plications and short -term efficacy of the two groups were compared .Results The operation time in observation group was (274.7 ±67.3) min which had no significant difference than (255.4 ±49.1)min in control group (P>0.05).The peri-operative bleeding, the hospital stay time and the chest tube duration were significantly less than the control group .The recurrence rate in observation group was 6.3%(6/96) which was significantly less than 17.0%(16/94) in control group (P<0.05).And the survival rate in observation group was 94.8%(91/96) which was significantly higher than 84.0%(79/94) in control group.Conclusion Thoracoscope and abdominoscope combined with minimally invasive esophageal surgery has a great clinical efficacy .